Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis

EU orphan designation number: EU/3/09/689   
Active ingredient: Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis
Indication: Treatment of myasthenia gravis
Sponsor: CuraVac Europe SA
Avenue de Villefranche 80, B-1330 Rixensart, Belgique

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/11/2009 Centralised Orphan - Designation EMEA/OD/078/09 (2009)8764 of 09/11/2009
24/01/2014 Centralised Orphan - Change of address